Home World Politics Business Tech Health Science Climate Education

Balanced coverage of the week's biggest story. See every side. Know the truth.

By signing up for the Story of the Week newsletter you agree to our privacy policy.

Product

For You
Trending
Blindspot
Local
Compare
Brief
Trust

Topics

World
Politics
Business
Tech
Health
Science

Regions

Africa
Europe
Asia-Pacific
Americas
Middle East

Company

About
All topics
My Bias
Privacy
Terms & DMCA

KODAWIRE

KODAWIRE

© 2026 Kodawire

About Privacy Terms Top

/

/

Pharma major Novartis falls 10% after three drug trial setbacks

1 sources

CNBC47h ago

Center

Pharma major Novartis falls 10% after three drug trial setbacks

Shares of Novartis tanked on Tuesday after results from its del-desiran drug trial disappointed investors.

Spectrum

L 0%C 100%R 0%